These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19188143)

  • 1. A new fork for clinical application: targeting forkhead transcription factors in cancer.
    Yang JY; Hung MC
    Clin Cancer Res; 2009 Feb; 15(3):752-7. PubMed ID: 19188143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the role of forkhead transcription factors in cancer therapy.
    Yang JY; Hung MC
    Curr Drug Targets; 2011 Aug; 12(9):1284-90. PubMed ID: 21443462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO transcription factors in cancer development and therapy.
    Coomans de Brachène A; Demoulin JB
    Cell Mol Life Sci; 2016 Mar; 73(6):1159-72. PubMed ID: 26686861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer.
    Arden KC
    Exp Gerontol; 2006 Aug; 41(8):709-17. PubMed ID: 16806782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
    Zhu H
    Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO Signaling Pathways as Therapeutic Targets in Cancer.
    Farhan M; Wang H; Gaur U; Little PJ; Xu J; Zheng W
    Int J Biol Sci; 2017; 13(7):815-827. PubMed ID: 28808415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "O" class: crafting clinical care with FoxO transcription factors.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO transcription factors: their clinical significance and regulation.
    Wang Y; Zhou Y; Graves DT
    Biomed Res Int; 2014; 2014():925350. PubMed ID: 24864265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO3a: a novel player in thyroid carcinogenesis?
    Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
    Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pathway from JNK through decreased ERK and Akt activities for FOXO3a nuclear translocation in response to UV irradiation.
    Wang X; Chen WR; Xing D
    J Cell Physiol; 2012 Mar; 227(3):1168-78. PubMed ID: 21604264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer.
    Reagan-Shaw S; Ahmad N
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):360-8. PubMed ID: 17275054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy.
    Wilson MS; Brosens JJ; Schwenen HD; Lam EW
    Curr Drug Targets; 2011 Aug; 12(9):1256-66. PubMed ID: 21443467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluating the role of FOXOs in cancer.
    Hornsveld M; Dansen TB; Derksen PW; Burgering BMT
    Semin Cancer Biol; 2018 Jun; 50():90-100. PubMed ID: 29175105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance.
    Zhao F; Lam EW
    Front Med; 2012 Dec; 6(4):376-80. PubMed ID: 23124885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.
    Paik JH; Kollipara R; Chu G; Ji H; Xiao Y; Ding Z; Miao L; Tothova Z; Horner JW; Carrasco DR; Jiang S; Gilliland DG; Chin L; Wong WH; Castrillon DH; DePinho RA
    Cell; 2007 Jan; 128(2):309-23. PubMed ID: 17254969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation.
    Mei Y; Zhang Y; Yamamoto K; Xie W; Mak TW; You H
    Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5153-8. PubMed ID: 19276113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxO proteins: regulation and molecular targets in liver cancer.
    Carbajo-Pescador S; Mauriz JL; García-Palomo A; González-Gallego J
    Curr Med Chem; 2014 Apr; 21(10):1231-46. PubMed ID: 24372208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned?
    Zhang X; Rielland M; Yalcin S; Ghaffari S
    Curr Drug Targets; 2011 Aug; 12(9):1267-83. PubMed ID: 21443463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.